SEC Tracker
Get the app

Quest Diagnostics DGX

Catherine T. Doherty (Executive Vice President) sold 22,105 DGX at $248.02, worth $5.5M, under a 10b5-1 plan

Form
4
Filed
Importance
Routine
  1. Sold 4,827 shares at $0
  2. Sold 22,105 shares at $121.805
  3. Sold multiple batches of shares at prices between $244.84 and $251.24

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Quest Diagnostics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. Labcorp Holdings LH public float $21.7B, Jun 30, 2025
  2. Natera NTRA public float $21.8B, Jun 30, 2025
  3. Exact Sciences EXAS public float $10.0B, Jun 30, 2025
  4. Guardant Health GH public float $6.2B, Jun 30, 2025
  5. RadNet RDNT public float $4.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.